Fetal Distress

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Raydiant Oximetry
Raydiant OximetryCA - San Ramon
2 programs
ISS DeviceN/A1 trial
Raydiant Oximetry Sensing SystemN/A1 trial
Active Trials
NCT04081584Terminated4Est. Jun 2021
NCT04081623Terminated9Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Raydiant OximetryISS Device
Raydiant OximetryRaydiant Oximetry Sensing System

Clinical Trials (2)

Total enrollment: 13 patients across 2 trials

Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering

Start: Jul 2019Est. completion: Jun 20214 patients
N/ATerminated
NCT04081623Raydiant OximetryRaydiant Oximetry Sensing System

Trans-abdominal Fetal Pulse Oximetry: Signal Integrity

Start: Apr 2019Est. completion: Jun 20219 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space